Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 6, 2016, Pages 1045-1052

  Kennard, Alice ^a   Hawley, Carmel ^a,b,c   Tate, Jill ^d   Klingberg, Sandra ^d   Pretorius, Carel ^d   Hutchison, Colin ^e   Mollee, Peter ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e Hawke's Bay District Health Board   (New Zealand)

Author keywords

end stage kidney disease (ESKD); free light chain; Freelite; haemodialysis; kappa; lambda; light chain assay; N Latex; renal failure

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LATEX;

ADULT; ARTICLE; CLEARANCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; END STAGE RENAL DISEASE; FREE LIGHT CHAIN ASSAY; GLOMERULONEPHRITIS; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTICENTER STUDY; PARAPROTEINEMIA; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SERODIAGNOSIS; BLOOD; COMPARATIVE STUDY; KIDNEY FAILURE, CHRONIC; PROCEDURES;

CROSS-SECTIONAL STUDIES; HEMODIAFILTRATION; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 84969804415     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0799     Document Type: Article

References (16)

1. Bradwell, AR, editor. Serum free light chain analysis, 5th ed. Birmingham: The Binding Site Ltd, 2008:167-73.
2. Abraham RS, Katzmann JA, Clark RJ, Bradwell AR, Kyle RA, Gertz MA. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003;119:274-8.
3. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900-2.
4. Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24.
5. Hoedemakers RM, Pruijt JF, Hol S, Teunissen E, Martens H, Stam P, et al. Clinical comparison of new monoclonal antibodybased nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis. Clin Chem Lab Med 2011:50:489-95.
6. Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol 2008;9:11.
7. Hutchison CA, Harding S, Hewins P, Mead GP, Townsend J, Bradwell AR, et al. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1684-90.
8. Jacobs JF, Hoedemakers RM, Teunissen E, Te Velthuis H. N Latex FLC serum free light-chain assays in patients with renal impairment. Clin Chem Lab Med 2014;52:853-9.
9. Tate J, Bazeley S, Klinberg S, Pretorius CJ, Hawley C, Mollee P. Comparison of the Freelite and N Latex srum free light chain (FLC) assays in chronic kidney disease [abstract]. Clin Biochem Rev 2012;33:S41.
10. Data from manufacturer's dialyser data sheets. www.fmc-ag.com, www.nipro.com, www.baxter.com.
11. Jenner W, Klingberg S, Tate JR, Wilgen U, Ungerer JP, Pretorius CJ. Combined light chain immunofixation to detect monoclonal gammopathy: A comparison to standard electrophoresis in serum and urine. Clin Chem Lab Med 2014;52:981-7.
12. MedCalc for Windows v. 15.2.2 (2015). www.medcalc.org.
13. Lavatelli F, Brambilla F, Valentini V, Rognoni P, Casarini S, Di Silvestre D, et al. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum. Biochim Biophys Acta 2011;1814:409-19.
14. Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. Clin J Am Soc Nephrol 2007;18:886-95.
15. Hutchison CA, Basnayake K, Cockwell P. Serum free light chain assessment in monoclonal gammopathy and kidney disease. Nat Rev Nephrol 2009;11:621-8.
16. Berlanga O, Carr-Smith H, Harding S. Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment. Clin Chem Lab Med 2014;52:e243-5.